Furthermore, in a small study involving 24 patients treated with anti-PD-1 or PD-L1 mAbs, the majority of the irAEs following vaccination with inactivated influenza vaccine were graded 1–2, therefore not requiring a change of ICI therapy [131]. This evidence concerns the gene PDCD1 and influenza.